z-logo
open-access-imgOpen Access
Genetic and epigenetic changes in aberrant crypt foci and serrated polyps
Author(s) -
Suehiro Yutaka,
Hinoda Yuji
Publication year - 2008
Publication title -
cancer science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.035
H-Index - 141
eISSN - 1349-7006
pISSN - 1347-9032
DOI - 10.1111/j.1349-7006.2008.00784.x
Subject(s) - hyperplastic polyp , dysplasia , aberrant crypt foci , pathology , colorectal cancer , adenoma , adenocarcinoma , epithelial dysplasia , carcinoma , biology , cancer , medicine , colonoscopy , colonic disease
Aberrant crypt foci (ACF) in colorectal mucosa are the earliest known morphological precursors to colorectal cancer and can be subclassified as dysplastic, heteroplastic (non‐dysplastic), and mixed types. Serrated adenoma (SA) is a polyp with serrated architecture and dysplasia, and can be subclassified as traditional SA or sessile SA. Sessile SA is thought to be preneoplastic and differs from most lesions in the traditional SA category because of their flat morphology and general lack of cytological dysplasia. Serrated polyps include hyperplastic polyps (HP), SA, and admixed hyperplastic‐adenomatous polyps and are considered a morphological continuum encompassing heteroplastic ACF, HP, admixed hyperplastic‐adenomatous polyps, and SA. Recent studies have uncovered other developmental pathways including a heteroplastic ACF‐HP/SA‐carcinoma sequence and a heteroplastic ACF–adenoma–carcinoma sequence. Heteroplastic ACF histopathologically resemble HP and SA. Sporadic HP are usually present in the left colon, are small, and are considered benign. However, adenocarcinoma arising in the setting of colorectal HP or SA, especially in patients with hyperplastic polyposis, has been described. The relationship between heteroplastic ACF, HP, and colorectal cancer is less certain than that of dysplastic ACF. Here, we discuss the current understanding of genetic and epigenetic alterations in the development of colorectal cancer. Our goal is to provide a conceptual framework for understanding the heteroplastic ACF–HP/SA–carcinoma sequence. ( Cancer Sci 2008; 99: 1071–1076)

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here